ArticleCureus2024
In Vitro Antioxidant Activity of Green-Synthesized Zinc Oxide (ZnO) Nanoparticles Utilizing Extracts From Allium sativum.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- ZnO and rGO-Based nanoparticles regulate morphophysiological, biochemical, and molecular responses of Phaseolus vulgaris L. under drought and arsenic stress.BMC plant biology · 2026Article
- Development, Characterization, and Evaluation of the Antidepressant Potential of Crocus sativus SLN Nasal Spray in a Drosophila melanogaster Model.Combinatorial chemistry & high throughput screening · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe primary objective of this study was to develop an environmentally friendly and efficient method for synthesizing zinc oxide (ZnO) nanoparticles (NPs), utilizing extracts from MATERIALS AND
methodsThe synthesis process involved utilizing extracts from garlic plants to create ZnO NPs. The NPs were subjected to comprehensive characterization through UV-visible (UV-vis) spectroscopy, Fourier-transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), and X-ray diffraction (XRD). Antibacterial properties were assessed against different microbial strains. In vitro antioxidant properties were evaluated through 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2-azino-bis-3-ethylbenzothiazoline-6-sulphonic acid (ABTS) assays. Bioactive compounds in the synthesized NPs were also identified.
resultsAnalysis of the UV-vis spectrum confirmed the synthesis of ZnO NPs with an approximate size of 280 nm, as indicated by the absorption peak in the surface plasmon resonance band. FTIR spectroscopy revealed the presence of functional groups such as hydroxyl and carboxyl groups. SEM analysis determined the dimensions of the NPs to be around 11 nm. XRD patterns exhibited distinct Bragg reflections, confirming specific crystallographic planes. In vitro antioxidant assays demonstrated a reduction in absorbance at 517 nm and 734 nm, indicating antioxidant activity. Antibacterial testing revealed inhibition zones against
conclusionThe study successfully synthesized ZnO NPs using an eco-friendly method with garlic plant extracts. Characterization techniques confirmed the structural and chemical properties of the NPs. The synthesized NPs exhibited antioxidant and antibacterial activities, showcasing their potential for various applications. The identification of bioactive compounds further contributes to the understanding of the biological properties of the synthesized NPs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.